A citation-based method for searching scientific literature

Harold E Bays, Plamen Kozlovski, Qing Shao, Pieter Proot, Deborah Keefe. Obesity (Silver Spring) 2020
Times Cited: 5







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes.
Heidi Storgaard, Frederik Cold, Lise L Gluud, Tina Vilsbøll, Filip K Knop. Diabetes Obes Metab 2017
45
20

The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes.
Alexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, Andrew G Reaume, Michael S Saporito. J Pharmacol Exp Ther 2012
20
20

Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.
Edgar D Charles, Brent A Neuschwander-Tetri, Juan Pablo Frias, Sudeep Kundu, Yi Luo, Giridhar S Tirucherai, Rose Christian. Obesity (Silver Spring) 2019
55
20

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.
Faruk H Moonschi, Corey B Hughes, George M Mussman, John L Fowlkes, Chris I Richards, Iuliana Popescu. Acta Diabetol 2018
7
20



Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Dalong Zhu, Shenglian Gan, Yu Liu, Jianhua Ma, Xiaolin Dong, Weihong Song, Jiao'e Zeng, Guixia Wang, Wenjuan Zhao, Qiu Zhang,[...]. Lancet Diabetes Endocrinol 2018
14
20

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll. PLoS One 2016
91
20

A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus.
Moon-Kyu Lee, Sin Gon Kim, Elaine Watkins, Min Kyong Moon, Sang Youl Rhee, Juan P Frias, Choon Hee Chung, Seung-Hwan Lee, Bradley Block, Bong Soo Cha,[...]. J Diabetes Complications 2020
3
33


Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.
R Grempler, L Thomas, M Eckhardt, F Himmelsbach, A Sauer, D E Sharp, R A Bakker, M Mark, T Klein, P Eickelmann. Diabetes Obes Metab 2012
314
20

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.
Jennifer R Donnan, Catherine A Grandy, Eugene Chibrikov, Carlo A Marra, Kris Aubrey-Bassler, Karissa Johnston, Michelle Swab, Jenna Hache, Daniel Curnew, Hai Nguyen,[...]. BMJ Open 2019
46
20

Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis.
Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima. Hepatol Res 2019
22
20

Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Derek J Nunez, Mark A Bush, David A Collins, Susan L McMullen, Dawn Gillmor, Glen Apseloff, George Atiee, Leonor Corsino, Linda Morrow, Paul L Feldman. PLoS One 2014
42
20

SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models.
Pang-ke Yan, Li-na Zhang, Ying Feng, Hui Qu, Li Qin, Lian-shan Zhang, Ying Leng. Acta Pharmacol Sin 2014
3
33

Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.
Yong-Chao Qiao, Wei Ling, Yan-Hong Pan, Yin-Ling Chen, Dan Zhou, Yan-Mei Huang, Xiao-Xi Zhang, Hai-Lu Zhao. Oncotarget 2017
15
20



Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
Salvatore Petta, Luca Miele, Elisabetta Bugianesi, Calogero Cammà, Chiara Rosso, Stefania Boccia, Daniela Cabibi, Vito Di Marco, Stefania Grimaudo, Antonio Grieco,[...]. PLoS One 2014
71
20

Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease.
Sarah Shili-Masmoudi, Grace Lai-Hung Wong, Jean-Baptiste Hiriart, Ken Liu, Faiza Chermak, Sally She-Ting Shu, Juliette Foucher, Yee-Kit Tse, Pierre-Henri Bernard, Terry Cheuk-Fung Yip,[...]. Liver Int 2020
9
20

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Mohammad S Siddiqui, Raj Vuppalanchi, Mark L Van Natta, Erin Hallinan, Kris V Kowdley, Manal Abdelmalek, Brent A Neuschwander-Tetri, Rohit Loomba, Srinivasan Dasarathy, Danielle Brandman,[...]. Clin Gastroenterol Hepatol 2019
74
20

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo,[...]. Gastroenterology 2016
298
20

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.
Eric Lefebvre, Graeme Moyle, Ran Reshef, Lee P Richman, Melanie Thompson, Feng Hong, Hsin-L Chou, Taishi Hashiguchi, Craig Plato, Dominic Poulin,[...]. PLoS One 2016
140
20

Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity.
Silvia Sookoian, Gustavo O Castaño, Romina Scian, Pablo Mallardi, Tomas Fernández Gianotti, Adriana L Burgueño, Julio San Martino, Carlos J Pirola. Hepatology 2015
113
20


Applicability of BARD score to Japanese patients with NAFLD.
H Fujii, M Enomoto, W Fukushima, A Tamori, H Sakaguchi, N Kawada. Gut 2009
29
20

Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial.
Ricardo U Macías-Rodríguez, Hermes Ilarraza-Lomelí, Astrid Ruiz-Margáin, Sergio Ponce-de-León-Rosales, Florencia Vargas-Vorácková, Octavio García-Flores, Aldo Torre, Andrés Duarte-Rojo. Clin Transl Gastroenterol 2016
43
20

Nonalcoholic fatty liver disease and obstructive sleep apnea.
Judith Aron-Wisnewsky, Karine Clement, Jean-Louis Pépin. Metabolism 2016
46
20

The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.
David Tendler, Sauyu Lin, William S Yancy, John Mavropoulos, Pam Sylvestre, Don C Rockey, Eric C Westman. Dig Dis Sci 2007
111
20

A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis.
Baek Gyu Jun, Won Young Park, Eui Ju Park, Jae Young Jang, Soung Won Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho,[...]. PLoS One 2017
13
20

Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
Vasilios G Athyros, Chrysa Boutari, Konstantinos Stavropoulos, Panagiotis Anagnostis, Konstantinos P Imprialos, Michael Doumas, Asterios Karagiannis. Curr Vasc Pharmacol 2018
27
20

Tropifexor-Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents.
Eloy D Hernandez, Lianxing Zheng, Young Kim, Bin Fang, Bo Liu, Reginald A Valdez, William F Dietrich, Paul V Rucker, Donatella Chianelli, James Schmeits,[...]. Hepatol Commun 2019
19
20

Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Hui-Jie Zhang, Jiang He, Ling-Ling Pan, Zhi-Min Ma, Cheng-Kun Han, Chung-Shiuan Chen, Zheng Chen, Hai-Wei Han, Shi Chen, Qian Sun,[...]. JAMA Intern Med 2016
76
20

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Christophe Cassinotto, Jérome Boursier, Victor de Lédinghen, Jérome Lebigot, Bruno Lapuyade, Paul Cales, Jean-Baptiste Hiriart, Sophie Michalak, Brigitte Le Bail, Victoire Cartier,[...]. Hepatology 2016
180
20

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Eric A Klein, Ian M Thompson, Catherine M Tangen, John J Crowley, M Scott Lucia, Phyllis J Goodman, Lori M Minasian, Leslie G Ford, Howard L Parnes, J Michael Gaziano,[...]. JAMA 2011
829
20

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Vlad Ratziu, Julien Massard, Frederic Charlotte, Djamila Messous, Françoise Imbert-Bismut, Luninita Bonyhay, Mohamed Tahiri, Mona Munteanu, Dominique Thabut, Jean François Cadranel,[...]. BMC Gastroenterol 2006
264
20

Medical liver biopsy: background, indications, procedure and histopathology.
Alexander Boyd, Owen Cain, Abhishek Chauhan, Gwilym James Webb. Frontline Gastroenterol 2020
6
20

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease.
Halina Cichoż-Lach, Krzysztof Celiński, Beata Prozorow-Król, Jarosław Swatek, Maria Słomka, Tomasz Lach. Med Sci Monit 2012
22
20

Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.
F Guzmán-Aroca, M D Frutos-Bernal, A Bas, J A Luján-Mompeán, M Reus, Juan de Dios Berná-Serna, P Parrilla. Eur Radiol 2012
37
20

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
S Petta, S Ciminnisi, V Di Marco, D Cabibi, C Cammà, A Licata, G Marchesini, A Craxì. Aliment Pharmacol Ther 2017
87
20


One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Mary Ann Huang, Joel K Greenson, Cewin Chao, Lilian Anderson, Debra Peterman, Jon Jacobson, Dawn Emick, Anna S Lok, Hari S Conjeevaram. Am J Gastroenterol 2005
271
20

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Jill C Keach, Heather D Lafferty, Alisha Stahler,[...]. Gastroenterology 2015
20

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
Serena Pelusi, Salvatore Petta, Chiara Rosso, Vittorio Borroni, Anna Ludovica Fracanzani, Paola Dongiovanni, Antonio Craxi, Elisabetta Bugianesi, Silvia Fargion, Luca Valenti. PLoS One 2016
28
20

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
C A Matteoni, Z M Younossi, T Gramlich, N Boparai, Y C Liu, A J McCullough. Gastroenterology 1999
20

Liver Steatosis and Fibrosis in OSA patients After Long-term CPAP Treatment: A Preliminary Ultrasound Study.
Maria Buttacavoli, Claudia I Gruttad'Auria, Mirko Olivo, Roberto Virdone, Alessandra Castrogiovanni, Emilia Mazzuca, Anna Maria Marotta, Oreste Marrone, Salvatore Madonia, Maria R Bonsignore. Ultrasound Med Biol 2016
14
20




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.